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CASE REPORT
Sarcoidosis is a multisystemic disorder of un-
known cause, characterized by widespread non-
caseating granuloma, and commonly affects the
young adult. The clinical presentation of the dis-
ease is protean. It may involve the chest, skin,
eye, liver, spleen and nervous system. Sarcoidosis
is uncommon among Chinese people. In Taiwan,
the first case was reported in 1960. The incidence
rate was only 0.027 per thousand admissions 
between 1990 and 1995.1 Family history seemed
a strong risk factor to induce sarcoidosis, espe-
cially in African-Americans.2 Substantial evidence
exists for a genetic predisposition to sarcoidosis.
However, no cases of familial sarcoidosis have
been reported among Chinese people. Herein, we
report a familial case of sarcoidosis in Taiwan
with human leukocyte antigen (HLA)-typing
performed.
Case Reports
Case 1
Mrs Huang, a 56-year-old lady, had experienced
dry cough for 3 months and was admitted to hos-
pital in May 1993. She was the president of an 
elementary school. She was robust in the past.
Major systemic disease or cigarette smoking was
denied. Physical examination was unremarkable
except for two small erythematous papules over
the face. Chest radiography showed a nodular
shadow near the aortic knob. An anterior medi-
astinal mass was suspected. Chest computed
tomography (CT) with contrast revealed enlarged
lymph nodes over bilateral upper and lower para-
tracheal, right tracheobronchial, aorto-pulmonary
window, subcarinal and bilateral intrapulmonary
areas (Figure 1). Pulmonary function test (PFT)
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disclosed mild restrictive ventilatory impairment
(FEV1: 1.38 L, 61%; forced vital capacity [FVC]:
1.85 L, 67% predicated; FEV1/FVC = 74%; total
lung capacity: 3.46 L, 80% predicated). Diffusing
capacity of carbon monoxide (DLco) showed mod-
erate reduction of gas exchange (DLco: 13 mL/
mmHg/min, 54% predicated; DLco/alveolar vol-
ume [VA]: 4.26 L/min/mmHg, 83% predicated).
No hypercalcemia or hypercalciuria was noted.
Bronchoscopy was performed, which showed dif-
fuse capillary engorgement and congestion in left
bronchial trees. Additionally, the lumen of the
left main bronchus was also narrowed. Broncho-
scopic biopsy was performed via the left common
basal bronchus. Mediastinoscopic biopsy of left
paratracheal lymph nodes and skin biopsy of the
facial lesion were also performed. All the pathol-
ogy results showed chronic non-caseating granu-
lomatous inflammation (Figure 2). Sarcoidosis
with mediastinum and skin involvement was im-
pressed. The HLA-typing of the patient was HLA-
A2, A11, B35, B39, CW4, CW7, DR8 and DQ6.
She was regularly followed up in the outpatient
department without steroid use. No progression in
clinical symptoms and chest films were observed
between 1993 and 2004. (She refused chest CT ex-
amination after initial diagnosis due to no further
discomfort.)
Case 2
Mr Huang, the son of Mrs Huang, a 43-year-old
male, was admitted in February 2004 due to
chronic cough. He was a current smoker of one
pack per day for 20 years. He was an engineer 
in the Metro Taipei, but he had never worked 
in the tunnel. His past medical history was nega-
tive for major systemic diseases. Physical exami-
nation and laboratory data were unremarkable.
Chest radiography revealed bilateral hilar en-
largement without infiltration (Figure 3). Chest
CT showed multiple lymphadenopathy over the
subcarinal, pretracheal and paratracheal regions.
PFT showed normal ventilation function. DLco
indicated moderate reduction of gas exchange
(DLco: 18.5 mL/mmHg/min, 55% predicated;Figure 1. Chest computed tomography of case 1 shows
enlarged lymph nodes over bilateral upper and lower para-
tracheal, right tracheobronchial, aortopulmonary window,
subcarinal and bilateral intrapulmonary areas.
Figure 2. Pathology of left paratracheal lymph nodes of
case 1 shows chronic non-caseating granulomatous inflam-
mation (hematoxylin & eosin stain, 100×).
Figure 3. Chest radiograph of case 2 shows bilateral hilar
enlargement.
DLco/VA: 4.07 L/min/mmHg, 75% predicated).
No hypercalcemia was noted. Bronchoscopy was
performed with negative findings. Mediastino-
scopy was performed, and paratracheal, tracheo-
bronchial and subcarinal lymph nodes were taken
for pathologic examination. Pathology results
showed chronic non-caseating granulomatous in-
flammation (Figure 4). Pulmonary sarcoidosis
stage I was diagnosed. The HLA-typing of this 
patient was HLA-A2, A24, B39, B48, CW7, CW8,
DR8 and DQ6. He was also followed up in the
outpatient department without steroid use. He
was lost to follow-up due to immigration to the
United States of America.
As previously mentioned, his mother was diag-
nosed with sarcoidosis 11 years ago. No other
family members were diagnosed with sarcoidosis.
They did not receive examination of HLA-typing
because they did not live in Taiwan.
Discussison
Sarcoidosis is a granulomatous disease of un-
known etiology, affecting multiple organs. Esti-
mates of the prevalence of sarcoidosis range from
less than one case to 40 cases per 100,000 popu-
lation, with an age-adjusted annual incidence in
the United States of 10.9 per 100,000 for whites
and 35.3 per 100,000 for blacks.1 In Taiwan, 
although the disease-specific rate per thousand
admissions increased from 0.004 in the 1980s to
0.027 in the 1990s, sarcoidosis remains an un-
common disease.2
Although sarcoidosis can affect multiple or-
gans, the lungs or intrathoracic lymph nodes are
involved in more than 90% of patients with the
disease.1 The most common symptoms of pul-
monary sarcoidosis are shortness of breath, dry
cough and chest discomfort.1 Radiologic appear-
ance is classified into five stages.1 Radiographic
staging can be utilized as a prognostic factor and
act as a guide for treatment.1,3–5
Diagnosis of sarcoidosis is based on a com-
patible clinical picture, histologic evidence of non-
caseating granuloma and excluding other known
causes contributing to this pathologic response.1
Biopsy by fiberobronchoscopy is the most fre-
quent procedure used to diagnose pulmonary
sarcoidosis.6,7 Marked increase in the proportion
of lymphocytes recovered from bronchoalveolar
lavage (BAL) was observed in active pulmonary
sarcoidosis. In the majority, BAL lymphocytosis
is typified by a dominance of CD4+ T cells in
contrast to the CD8+ BAL lymphocytosis seen in
patients with hypersensitivity pneumonitis, viral
infection, and many drug reactions.8,9 Mediasti-
noscopy is considered for cases in which lym-
phoma or other intrathoracic malignancy cannot
be reasonably excluded.1
Observation is suggested in asymptomatic
patients or those with mild disease.1,10 Sponta-
neous remission or disease stabilization is reported
to occur in approximately two thirds of cases.1 In
general, oral conticosteroids are indicated as the
first-line treatment for severe ocular, neurologic,
or cardiac sarcoidosis, malignant hypercalcemia,
symptomatic or progressive stage II pulmonary
disease (as reflected by serial pulmonary function
decline) and stage III pulmonary disease.10
Several factors are thought to be related to the
disease, such as environment, gene and immu-
nology.1 Genetic factors may play a part in the
predisposition to sarcoidosis.11 At present, race and
family history of disease are the most strongly
identified risk factors to developing sarcoidosis,
thus supporting the notion that there is a genetic
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Figure 4. Pathology of subcarinal lymph nodes of case 2
shows chronic non-caseating granulomatous inflammation
(hematoxylin & eosin stain, 100×).
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susceptibility to the development of this disease.
Familial aggregation and racial difference in dis-
ease incidence have been reported worldwide,
ranging from 4.3% (Japan), 4.7% (Finland), 5.9%
(UK), to 17% (African-Americans).12,13 In the
United States, African-Americans are at least four
times more likely to develop the disease than are
white Americans.14,15 Within the same family, sib-
ling pairs are most common and mother–daughter
pairs are more frequent than father–son pairs.
Monozygotic twins appear more likely to have
sarcoidosis than dizygotic twins, strongly suggest-
ing a genetic component to the disease. It is likely
that the genetic susceptibility to sarcoidosis in-
volves several genes.16 Siblings had the highest
relative risk, followed by avuncular relationships,
grandparents and then parents.15 Genetics may be
important not only in defining the risk of disease,
but also in determining the pattern of disease, its
severity and prognosis.17
Candidate gene associations with sarcoidosis
risk remain unconfirmed. These genes may be
involved in T cell function, regulation of antigen
recognition and processing, or the regulation 
of matrix deposition that favors granuloma for-
mation and progressive fibrosis.1,16 The major
histocompatibility complex (MHC) region, on
chromosome 6p, was an important target of 
investigation. Association studies and linkage
analysis support the idea that candidate disease
susceptibility gene(s) of the human genome is
located on the short arm of chromosome 6.1
This is also the locus of the MHC, which is a crit-
ical part of the human immune system. Studies
have suggested that genes encoding the HLA 
portion of the MHC play an important role in
determining the risk and clinical course of sar-
coidosis. They pointed out that B8 and CW7
antigens prevail in patients suffering from the dis-
ease as compared with a control group of healthy
people.18,19 In another study, which recruited pa-
tients with pulmonary sarcoidosis in nothern
Poland, antigens HLA-B8 and CW7 are signifi-
cantly more frequent as compared with the con-
trol group of healthy people.20 Besides the HLA
genes conferring susceptibility, they may also be
involved in disease outcomes. In addition, poly-
morphisms in genes of the interleukin-1 family,
vitamin D receptor and the promoter region of
the gene for tumor necrosis factor-α have been
reported to be associated with the pathogenesis
of sarcoidosis.21 In contrast, there have been few
gene studies of familial sarcoidosis. One study that
genotyped 122 affected siblings from 55 families
in Germany showed significant excess of marker
haplotype sharing among affected siblings, espe-
cially at marker locus D6S 1666 in the class III
gene cluster.22 Genotyping for HLA-DQB1 has
also been studied in familial sarcoidosis.23 Over-
representation of DQB1*0603 and DQB1*0604
among alleles shared by affected first degree 
relatives was concluded.
After a thorough search of the literature via
MEDLINE and PubMed, we found that no cases
of familial sarcoidosis have been reported among
Chinese people. This is the first report of familial
sarcoidosis among Chinese people, with HLA-
typing performed. In the two cases we reported,
they had some HLA loci in common, such as A2,
B39, CW7, DR8 and DQ6. If genetic factors pre-
disposing to sarcoidosis do exist, they may reside
in these loci. This assumption may be arbitrary
because the mother and her son may share the
common HLA in part. However, HLA-CW7 has
also been reported to be a frequent HLA locus in
English and Polish people with sarcoidosis.19,20
It seems reasonable that the same linkage may be
present in Chinese people. Nevertheless, more
cases are needed for further investigation of 
genetic predisposition.
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